Irene Velilla Martínez

Title: Irene Velilla Martínez: Innovator in Prostaglandin E2 Modulation

Introduction

Irene Velilla Martínez is a notable inventor based in Navarra, Spain. She has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of prostaglandin E2 (PGE2) receptors. Her innovative work has the potential to impact various medical conditions, including cancer and neurodegenerative diseases.

Latest Patents

Irene holds a patent for "N-benzyl-2-phenoxybenzamide derivatives as prostaglandin E2 (PGE2) receptors modulators." This invention relates to novel, optionally substituted, N-benzyl-2-phenoxybenzamide derivatives that serve as modulators of EP4 and/or EP2 receptors of PGE2. The patent outlines processes for their preparation, pharmaceutical compositions containing these compounds, and their application in treating conditions that can benefit from the modulation of these receptors, such as cancer, pain, inflammation, neurodegenerative diseases, and kidney diseases.

Career Highlights

Irene is currently associated with Medibiofarma, S.L., where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving therapeutic options for patients suffering from various ailments.

Collaborations

Irene has collaborated with notable colleagues, including Julio Castro Palomino Laria and Juan Camacho Gómez. These partnerships have contributed to the advancement of her research and the successful development of her patented inventions.

Conclusion

Irene Velilla Martínez exemplifies the spirit of innovation in the pharmaceutical industry. Her work on prostaglandin E2 receptor modulators showcases her dedication to addressing critical health challenges. Through her patents and collaborations, she continues to make a meaningful impact in the field of medicine.